Brokers Offer Predictions for HCA Healthcare FY2025 Earnings

HCA Healthcare, Inc. (NYSE:HCA) – Equities research analysts at Zacks Research increased their FY2025 earnings per share (EPS) estimates for shares of HCA Healthcare in a report issued on Friday, August 8th. Zacks Research analyst R. Department now anticipates that the company will earn $25.91 per share for the year, up from their previous forecast of $25.07. The consensus estimate for HCA Healthcare’s current full-year earnings is $24.98 per share. Zacks Research also issued estimates for HCA Healthcare’s Q1 2026 earnings at $6.82 EPS, Q2 2026 earnings at $6.68 EPS, Q3 2026 earnings at $5.75 EPS, Q4 2026 earnings at $7.38 EPS and FY2026 earnings at $26.62 EPS.

HCA has been the subject of several other reports. JPMorgan Chase & Co. increased their target price on HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a research report on Monday, August 4th. Royal Bank Of Canada lowered their price objective on HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a research report on Monday, July 28th. Barclays lowered their price objective on HCA Healthcare from $416.00 to $390.00 and set an “overweight” rating for the company in a research report on Monday, July 28th. Stephens upgraded HCA Healthcare to a “strong-buy” rating in a research report on Monday, June 2nd. Finally, Wall Street Zen raised HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, July 5th. Nine investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $395.69.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $382.90 on Monday. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The company has a market capitalization of $89.60 billion, a PE ratio of 16.10, a P/E/G ratio of 1.20 and a beta of 1.39. HCA Healthcare has a 12 month low of $289.98 and a 12 month high of $417.14. The stock has a 50-day moving average price of $369.76 and a two-hundred day moving average price of $350.02.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. HCA Healthcare’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the company earned $5.50 EPS.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.11%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. ORG Partners LLC lifted its holdings in shares of HCA Healthcare by 27.9% in the second quarter. ORG Partners LLC now owns 142 shares of the company’s stock valued at $55,000 after purchasing an additional 31 shares in the last quarter. Avantax Advisory Services Inc. lifted its holdings in shares of HCA Healthcare by 0.4% in the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock valued at $2,791,000 after purchasing an additional 32 shares in the last quarter. Glenview Trust co lifted its holdings in HCA Healthcare by 2.3% during the first quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after acquiring an additional 32 shares during the period. Horizon Investments LLC lifted its holdings in HCA Healthcare by 1.1% during the first quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock worth $1,097,000 after acquiring an additional 33 shares during the period. Finally, Sivia Capital Partners LLC lifted its holdings in HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after acquiring an additional 33 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.